首页> 美国卫生研究院文献>Journal of Diabetes and Metabolic Disorders >Effect of symbiotic supplementation on glycemic control lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized double-blind clinical trial
【2h】

Effect of symbiotic supplementation on glycemic control lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized double-blind clinical trial

机译:共生补充剂对非肥胖2型糖尿病患者血糖控制血脂和微蛋白尿的影响:一项随机双盲临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe prevalent raise of type 2 diabetes (T2D) around the globe, are creating higher risk for cardiovascular diseases (CVDs) and increasing strain on each country’s health care budget in the world. Microalbuminuria has appeared as a key parameter in diabetic patients. Microalbuminuria is also related to increased cardiovascular morbidity in people who are non-obese diabetic. Some studies have suggested that consumption of symbiotic foods might help improve the metabolic profile, inflammatory factors and biomarkers of oxidative stress. The aim of trial was to determine the effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in non-obese T2D.
机译:背景技术全球范围内2型糖尿病(T2D)的普遍上升正在给心血管疾病(CVD)带来更高的风险,并给世界各国的医疗保健预算增加了压力。微量白蛋白尿已成为糖尿病患者的关键参数。非肥胖糖尿病患者的微量白蛋白尿还与心血管疾病的发病率增加有关。一些研究表明,食用共生食品可能有助于改善代谢状况,炎性因子和氧化应激的生物标志物。该试验的目的是确定共混补充剂对非肥胖型T2D患者血糖控制,脂质分布和微量白蛋白尿的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号